The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
69084534 6908453 4 F 20160822 20090212 20160822 EXP GB-BRISTOL-MYERS SQUIBB COMPANY-14502066 BRISTOL MYERS SQUIBB 0.00 M Y 0.00000 20160822 MD GB GB

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
69084534 6908453 1 PS REYATAZ ATAZANAVIR SULFATE 1 Transplacental 300 MG, QD U 21567 300 MG CAPSULE, HARD QD
69084534 6908453 2 SS DIDANOSINE. DIDANOSINE 1 Transplacental 200 MG, QD U 0 200 MG POWDER FOR ORAL SOLUTION QD
69084534 6908453 3 SS VIREAD TENOFOVIR DISOPROXIL FUMARATE 1 Transplacental 245 MG, QD U 0 245 MG QD
69084534 6908453 4 SS RITONAVIR. RITONAVIR 1 Transplacental 100 MG, QD U 0 100 MG QD
69084534 6908453 5 SS TRUVADA EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE 1 Transplacental 1 DF, QD U 0 1 DF QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
69084534 6908453 1 Product used for unknown indication
69084534 6908453 2 Product used for unknown indication
69084534 6908453 3 Product used for unknown indication
69084534 6908453 4 Product used for unknown indication
69084534 6908453 5 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
69084534 6908453 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
69084534 6908453 Foetal distress syndrome
69084534 6908453 Foetal exposure during pregnancy

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
69084534 6908453 1 2002 20081119 0
69084534 6908453 2 2002 20080630 0
69084534 6908453 3 2002 20080630 0
69084534 6908453 4 2002 20081119 0
69084534 6908453 5 20080630 20080630 0